Search clinical trials for: HT-001 1% Topical Gel

Total 1055 results

Taro Pharmaceuticals USA

Completed

A Study Comparing Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel to Duac® Topical Gel in the Treatment of Acne Vulgaris

Acne Vulgaris
Thomas Jefferson University

Completed

STOPAIN in the Treatment of a Single Migraine Attack

Migraine | Headache

United States
Ralexar Therapeutics, Inc.

Completed

A Study in Subjects With Moderate Atopic Dermatitis

Atopic Dermatitis | Eczema, Atopic

United States
Dermata Therapeutics

Completed

DMT210 Topical Gel in the Treatment of Atopic Dermatitis

Atopic Dermatitis

United States
Amneal Pharmaceuticals, LLC
Sristek Clinical Research Solutions Limited

Completed

Study Comparing a Generic Diclofenac Sodium Topical Gel, 1% to Voltaren in the Treatment of Subjects With Osteoarthritis of the Knee

Osteoarthritis

India
Universidad Católica de Ávila

Active, not recruiting

Effectiveness Of A Physiotherapy Treatment Plan In Lateral Epicondylalgia

Humeral Epicondylitis, Lateral

Spain
Veloce BioPharma LLC

Completed

A Study of VBP-245 in Pediatric Patients With Molluscum Contagiosum

Molluscum Contagiosum

United States
Photopharmica

Completed

Clinical Trial to Investigate Treatment With Photodynamic Therapy to Reduce Levels of Bacteria in Leg Ulcers

Wound Healing | Chronic Leg Ulcers

United Kingdom
Boston Medical Center
National Institute on Aging (NIA)

Terminated

TOM: Testosterone in Older Men With Sarcopenia

Muscular Diseases | Sarcopenia | Hypogonadism

United States
Ralexar Therapeutics, Inc.

Unknown

Study in Subjects With Moderate Atopic Dermatitis

Atopic Dermatitis Eczema

United States, Canada
Dermata Therapeutics

Completed

DMT210 Topical Gel in the Treatment of Acne Rosacea

Acne Rosacea

United States
Padagis LLC

Completed

Randomized Study to Compare the Bioavailability of Three Mometasone Furoate 0.1% Topical Lotions

Healthy
TWi Biotechnology, Inc.

Completed

Prophylactic Treatment of Skin Rash Associated With EGFR Inhibitor Therapy

EGFR Inhibitor-Induced Skin Rash

Taiwan
BioPharmX, Inc.

Unknown

Topical Minocycline Gel for Inflammatory Lesions of Papulopustular Rosacea (PRISM)

Papulopustular Rosacea

United States
Sol-Gel Technologies, Ltd.

Terminated

An Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas in Patients With Non-Gorlin High Frequency BCC

Recurrent Basal Cell Carcinoma

United States
Maruho Co., Ltd.

Unknown

Topical Ionic Contra-Viral Therapy in Actinic Keratosis

Actinic Keratosis

Netherlands
Aevi Genomic Medicine, LLC, a Cerecor company

Completed

PART A: Efficacy and Safety of AEVI-001 in Children and Adolescents With ADHD and With mGluR Mutations

Attention Deficit Hyperactivity Disorder

United States
PellePharm, Inc.

Completed

Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Subjects With Basal Cell Nevus Syndrome (Gorlin Syndrome)

Basal Cell Nevus Syndrome

United States, Spain, Germany, United Kingdom, Italy, France, Belgium, Canada, Denmark, Netherlands
Aevi Genomic Medicine, LLC, a Cerecor company

Completed

PART B: Efficacy and Safety of AEVI-001 in Children and Adolescents With ADHD and Without mGluR Mutations

Attention Deficit Hyperactivity Disorder

United States
TR Therapeutics

Completed

Efficacy Study of GLYC-101 to Evaluate Outcomes After Post-laser Ablation

Wounds

United States
Galderma R&D

Completed

A Pilot Study to Investigate Filiation Between Primary and Secondary Lesions in Acne Patients

Acne

Canada, France
Sol-Gel Technologies, Ltd.
Premier Research Group plc

Recruiting

Efficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas on the Face of Adults With Gorlin Syndrome

Gorlin Syndrome

United States
Lenus Therapeutics, LLC

Terminated

Evaluation of the Safety and Efficacy Study of RGN-137 Topical Gel for Junctional and Dystrophic Epidermolysis Bullosa (CELEB)

Dystrophic Epidermolysis Bullosa | Junctional Epidermolysis Bullosa

United States
GlaxoSmithKline

Completed

Study to Evaluate the Safety, Tolerability and Pharmacokinetic of Single and 14 Day Repeat Topical Application of GSK1940029

Acne Vulgaris

Australia
Al-Azhar University

Unknown

Topical Fluorescent Nanoparticles Conjugated Somatostatin Analog for Suppression and Bioimaging Breast Cancer

Skin Diseases | Breast Cancer | Skin Cancer

Egypt, Saudi Arabia
Aclaris Therapeutics, Inc.

Completed

Dose-Response Profile of A-101 in Subjects With Seborrheic Keratosis

Seborrheic Keratosis

United States
University of Southern California

Completed

Topical Treatment and Prevalence of P. Acnes

Surgical Site Infection

United States
Aevi Genomic Medicine, LLC, a Cerecor company

Completed

Pharmacokinetic and Tolerability Study of NFC-1 in Subjects Aged 6-17 Years With ADHD

Attention Deficit Disorder With Hyperactivity

United States
GlaxoSmithKline

Completed

Study to Investigate the Irritation Potential of GSK1940029 Gel

Acne Vulgaris

Australia
Guang'anmen Hospital of China Academy of Chinese...

Completed

Topical Tripterygium Wilfordii Gel for Moderate Activity Rheumatoid Arthritis

Arthritis, Rheumatoid

China
Glenmark Pharmaceuticals Ltd. India

Completed

To Study Generic Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel (Glenmark Generics, Ltd) in the Treatment of Acne Vulgaris.

Acne Vulgaris

United States, Belize
Padagis LLC

Completed

Clinical Study Between Two 1% Clindamycin/5% Benzoyl Peroxide Topical Gel Formulations

Acne Vulgaris
RegeneRx Biopharmaceuticals, Inc.
sigma-tau i.f.r. S.p.A.

Completed

Study of Thymosin Beta 4 in Patients With Venous Stasis Ulcers (SSVS)

Venous Stasis Ulcers

Italy, Poland
GlaxoSmithKline

Completed

DUAC® Early Onset Efficacy Study in Japanese Subjects

Acne Vulgaris

Japan
Starpharma Pty Ltd

Completed

Dose-ranging Study of SPL7013 Gel for the Prevention of Bacterial Vaginosis (BV)

Recurrent Bacterial Vaginosis (BV)
LEO Pharma

Completed

Pharmacokinetics of LEO 43204 Gel in Actinic Keratosis Administered Under Maximal Use Conditions

Actinic Keratosis

United States
Aurobindo Pharma Ltd

Withdrawn

Clinical Endpoint Bioequivalence Study of Adapalene Gel 0.1%

Acne Vulgaris
Minghui Pharmaceutical Pty Ltd

Not yet recruiting

MH004 Topical Cream in Healthy Adult Volunteers and Participants With Atopic Dermatitis or Rheumatoid Arthritis

Rheumatoid Arthritis | Atopic Dermatitis
Mahidol University

Completed

Effect of Transparent, Self-drying Silicone Gel on the Treatment of Hypertrophic Abdominal Scars

Hypertrophic Scars | Keloids

Thailand
Pfizer

Completed

RIPT of Ibuprofen Topical Gel

Pain

United States
HanAll BioPharma Co., Ltd.

Completed

Phase 2 Study of HL-009 Liposomal Gel to Treat Mild to Moderate Atopic Dermatitis

Mild to Moderate Atopic Dermatitis

United States
Vedic Lifesciences Pvt. Ltd.

Completed

Evaluating the Safety and Efficacy of the Probiotic Bifidobacterium Longum ES1 and the Post Biotic Heat-treated Bifidobacterium Longum ES1 (HT-ES1) on IBS Symptom Severity in Patients With Diarrhoea Predominant Irritable Bowel Syndrome

Irritable Bowel Syndrome With Diarrhea

India
Amazentis SA
Princeton Research Corporation

Completed

Human Skin Safety Testing of a Mitopure Topical Product Using a Human Repeat Insult Patch Test (HRIPT) in Healthy Volunteers (GLOW-Safety)

Irritation/Irritant | Sensitisation

United Kingdom
Instituto de Investigación Marqués de Valdecilla

Withdrawn

Efficacy, Safety, and Immunogenicity of Vaccine Reimmunization With a Third Homologous Versus Heterologous Dose Against COVID-19 in Patients Undergoing Solid Organ Transplantation. (REIN-TX)

Covid19

Spain
Alaa Gamal

Recruiting

Efficacy of K-Y Jelly in Prevention of Postoperative Sore Throat After Nasal Surgery

Postoperative Sore Throat

Egypt
Novan, Inc.

Completed

A Phase 2, 3 Arm Study of NVN1000 Gel and Vehicle Gel in Subjects With Acne

Acne Vulgaris

Dominican Republic, Honduras, Panama
Prism Pharma Co., Ltd.

Completed

Trial to Evaluate Topical C-82 in a Psoriasis Plaque Test

Psoriasis

Germany
Amazentis SA
proDERM GmbH

Completed

Evaluation of the Anti-aging Efficacy of a Novel Skin Health Product

Skin Aging

Germany
Amazentis SA
proDERM GmbH

Completed

Efficacy Study of a Novel Skin Health Product to Reduce an UVB Induced Erythema

Erythema | Skin Inflammation | Sun Damaged Skin

Germany
Zagazig University

Completed

Evaluation of Efficacy of Topical Flutamide in the Treatment of Acne Vulgaris

Acne Vulgaris Superficial Mixed Comedonal and Inflammatory

Egypt

3

Subscribe